Navigation Links
Medical vital-sign monitoring reduced to the size of a postage stamp

CORVALLIS, Ore. Electrical engineers at Oregon State University have developed new technology to monitor medical vital signs, with sophisticated sensors so small and cheap they could fit onto a bandage, be manufactured in high volumes and cost less than a quarter.

A patent is being processed for the monitoring system and it's now ready for clinical trials, researchers say. When commercialized, it could be used as a disposable electronic sensor, with many potential applications due to its powerful performance, small size, and low cost.

Heart monitoring is one obvious candidate, since the system could gather data on some components of an EKG, such as pulse rate and atrial fibrillation. Its ability to measure EEG brain signals could find use in nursing care for patients with dementia, and recordings of physical activity could improve weight loss programs. Measurements of perspiration and temperature could provide data on infection or disease onset.

And of course, if you can measure pulse rate and skin responses, why not a lie detector?

"Current technology allows you to measure these body signals using bulky, power-consuming, costly instruments," said Patrick Chiang, an associate professor in the OSU School of Electrical Engineering and Computer Science.

"What we've enabled is the integration of these large components onto a single microchip, achieving significant improvements in power consumption," Chiang said. "We can now make important biomedical measurements more portable, routine, convenient and affordable than ever before."

The much higher cost and larger size of conventional body data monitoring precludes many possible uses, Chiang said. Compared to other technologies, the new system-on-a-chip cuts the size, weight, power consumption and cost by about 10 times.

Some of the existing technologies that would compete with this system, such as pedometers currently in use to measure physical activity, cost $100 or more. The new electronics developed at OSU, by comparison, are about the size and thickness of a postage stamp, and could easily just be taped over the heart or at other body locations to measure vital signs.

Part of what enables this small size, Chiang said, is that the system doesn't have a battery. It harvests the sparse radio-frequency energy from a nearby device in this case, a cell phone. The small smart phone carried by hundreds of millions of people around the world can now provide the energy for important biomedical monitoring at the same time.

"The entire field of wearable body monitors is pretty exciting," Chiang said. "By being able to dramatically reduce the size, weight and cost of these devices, it opens new possibilities in medical treatment, health care, disease prevention, weight management and other fields."

The new technology could be used in conjunction with cell phones or other radio-frequency devices within about 15 feet, but the underlying micropowered system-on-a-chip technology can be run by other energy-harvested power sources, such as body heat or physical movement.

OSU will work to develop this technology in collaboration with private industry, an increasing area of emphasis for the university. In the past two years, private financing of OSU research has increased by 42 percent, and the university has signed 108 research-based licenses of OSU technology.


Contact: Patrick Chiang
Oregon State University

Related biology technology :

1. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
2. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
3. Global Medical Image Analysis Software Market Worth $2.4 Billion by 2017
4. Nanofibrillar cellulose film to ease performing medical tests
5. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
6. Germany Prioritizes Medical Biotechnology with New Initiatives
7. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
8. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
9. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
10. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
11. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
Post Your Comments:
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):